Displaying 1–25 of 284 results for Contract Service
The buzz may be around biologics, but the oral solid dose sector is still going strong
Despite negative public opinions and heavy demands, survey respondents indicate rising satisfaction and pride in their work
New business management solutions offer end-to-end manufacturing connections
Supply Chain: Transitioning from “forming and storming” to the desired “norming and performing” stages of project execution.
Can the industry fix its image problem?
Four contract manufacturers who are redefining what it means to outsource
ADC BIO’s innovative technology is helping to usher in oncology’s new age of therapeutic agents
A new study shows a projected doubling of sales volume by 2021, as China strives to catch up with the global market
Survey results reveal how slow-motion trends are driving biopharma growth.
To advance, the pharma industry must confront its digital transformation fears head-on
Sourcing high quality APIs in a cost and time efficient manner requires a detailed understanding of manufacturing regulations and global supply chains
Selecting the right vendor is critical for young companies. Here are six essential steps for making sure your company makes the right choice.
John Lunger, VP Manufacturing and Supply Chain Development, Adaptimmune on how autologous engineered T-cell therapies challenge traditional late stage and commercial pharma supply chains practices
With regulatory measures related to drug prices and rebates supported by both sides of Congress, manufacturers should be prepared for new challenges.
Atrium improves audits and complaints, change control, and product release processes with immediate access to information and operational visibility
Why good quality doesn't have to mean higher costs — in fact, it often means lower recall and warranty costs.
Signs that CRO turnover is impacting your productivity, speed to market and bottom line.
Technology is helping to de-mystify the digital landscape and drive quality throughout the product life cycle.
Why the Pharma Supply Chain is Ripe for Digital Transformation
Why M&A may dominate the 2018 biopharma contract manufacturing landscape and the future may depend on the industry’s response to consolidation.
Contract Manufacturing & Development's Big Pharma Ascendency
CDMOs perfect the art of survival in today’s multi-product world
Companies that manufacture, sell or dispense drugs in the European Union have until February 9, 2019 to comply – where does the industry stand?
How modern biopharma is cautiously melding new downstream technology into their processes.
The underlying drivers for CDMO Industry developments and what they mean for the pharma industry as a whole